Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma (Review)
- Authors:
- Hui Jing
- Jingyuan Song
- Junnian Zheng
-
Affiliations: Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China - Published online on: January 15, 2018 https://doi.org/10.3892/ol.2018.7795
- Pages: 3403-3408
This article is mentioned in:
Abstract
 |
|
Vogel WF, Abdulhussein R and Ford CE: Sensing extracellular matrix: An update on discoidin domain receptor function. Cell Signal. 18:1108–1116. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Valiathan RR, Marco M, Leitinger B, Kleer CG and Fridman R: Discoidin domain receptor tyrosine kinases: New players in cancer progression. Cancer Metastasis Rev. 31:295–321. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shrivastava A, Radziejewski C, Campbell E, Kovac L, McGlynn M, Ryan TE, Davis S, Goldfarb MP, Glass DJ, Lemke G and Yancopoulos GD: An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell. 1:25–34. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Playford MP, Butler RJ, Wang XC, Katso RM, Cooke IE and Ganesan TS: The genomic structure of discoidin receptor tyrosine kinase. Genome Res. 6:620–627. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Hou G, Vogel W and Bendeck MP: The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J Clin Invest. 107:727–735. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Quan J, Yahata T, Adachi S, Yoshihara K and Tanaka K: Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer. Int J Mol Sci. 12:971–982. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Nakada M, Kita D, Teng L, Pyko IV, Watanabe T, Hayashi Y and Hamada J: Receptor tyrosine kinases: Principles and functions in glioma invasion. Adv Exp Med Biol. 986:143–170. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang SH, Baek HA, Lee HJ, Park HS, Jang KY, Kang MJ, Lee DG, Lee YC, Moon WS and Chung MJ: Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas. Oncol Rep. 24:311–319. 2010.PubMed/NCBI | |
|
Shimada K, Nakamura M, Ishida E, Higuchi T, Yamamoto H, Tsujikawa K and Konishi N: Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer. Cancer Sci. 99:39–45. 2008.PubMed/NCBI | |
|
Nemoto T, Ohashi K, Akashi T, Johnson JD and Hirokawa K: Overexpression of protein tyrosine kinases in human esophageal cancer. Pathobiology. 65:195–203. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Willenbrock K, Kuppers R, Renne C, Brune V, Eckerle S, Weidmann E, Bräuninger A and Hansmann ML: Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica. 91:596–604. 2006.PubMed/NCBI | |
|
Song J, Chen X, Bai J, Liu Q, Li H, Xie J, Jing H and Zheng J: Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells. Tumour Biol. 37:11509–11521. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Toy KA, Valiathan RR, Núñez F, Kidwell KM, Gonzalez ME, Fridman R and Kleer CG: Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer. Breast Cancer Res Treat. 150:9–18. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G and Beckebaum S: Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer. 9:2272010. View Article : Google Scholar : PubMed/NCBI | |
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Maskarinec G, Pagano IS, Little MA, Conroy SM, Park SY and Kolonel LN: Mammographic density as a predictor of breast cancer survival: The Multiethnic Cohort. Breast Cancer Res. 15:R72013. View Article : Google Scholar : PubMed/NCBI | |
|
Tice JA, O'Meara ES, Weaver DL, Vachon C, Ballard-Barbash R and Kerlikowske K: Benign breast disease, mammographic breast density and the risk of breast cancer. J Natl Cancer Inst. 105:1043–1049. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ameli F, Rose IM and Masir N: Expression of DDR1 and DVL1 in invasive ductal and lobular breast carcinoma does not correlate with histological type, grade and hormone receptor status. Asian Pac J Cancer Prev. 16:2385–2390. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Egeblad M, Rasch MG and Weaver VM: Dynamic interplay between the collagen scaffold and tumor evolution. Current Opin Cell Biol. 22:697–706. 2010. View Article : Google Scholar | |
|
Vogel W, Gish GD, Alves F and Pawson T: The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell. 1:13–23. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Leitinger B: Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2. J Biol Chem. 278:16761–16769. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Abdulhussein R, McFadden C, Fuentes-Prior P and Vogel WF: Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor. J Biol Chem. 279:31462–31470. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Konitsiotis AD, Raynal N, Bihan D, Hohenester E, Farndale RW and Leitinger B: Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen. J Biol Chem. 283:6861–6868. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Xu H, Raynal N, Stathopoulos S, Myllyharju J, Farndale RW and Leitinger B: Collagen binding specificity of the discoidin domain receptors: Binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1. Matrix Biol. 30:16–26. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Leitinger B: Transmembrane collagen receptors. Annu Rev Cell Dev Biol. 27:265–290. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
L'Hote CG, Thomas PH and Ganesan TS: Functional analysis of discoidin domain receptor 1: Effect of adhesion on DDR1 phosphorylation. FASEB J. 16:234–236. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Koo DH, McFadden C, Huang Y, Abdulhussein R, Friese-Hamim M and Vogel WF: Pinpointing phosphotyrosine-dependent interactions downstream of the collagen receptor DDR1. FEBS Lett. 580:15–22. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Wang CZ, Su HW, Hsu YC, Shen MR and Tang MJ: A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. Mol Biol Cell. 17:2839–2852. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lemeer S, Bluwstein A, Wu Z, Leberfinger J, Müller K, Kramer K and Kuster B: Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1. J Proteomics. 75:3465–3477. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Nascimento AF, Raut CP and Fletcher CD: Primary angiosarcoma of the breast: Clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol. 32:1896–1904. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Petridis C, Brook MN, Shah V, Kohut K, Gorman P, Caneppele M, Levi D, Papouli E, Orr N, Cox A, et al: Genetic predisposition to ductal carcinoma in situ of the breast. Breast Cancer Res. 18:222016. View Article : Google Scholar : PubMed/NCBI | |
|
Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, et al: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 7:552007. View Article : Google Scholar : PubMed/NCBI | |
|
Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A, et al: The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res. 68:537–544. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Dejmek J, Dib K, Jonsson M and Andersson T: Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion. Int J Cancer. 103:344–351. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Islam N, Kwon SC, Senie R and Kathuria N: Breast and cervical cancer screening among South Asian women in New York city. J Immigr Minor Health. 8:211–221. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, et al: Molecular definition of breast tumor heterogeneity. Cancer Cell. 11:259–273. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Blick T, Hugo H, Widodo E, Waltham M, Pinto C, Mani SA, Weinberg RA, Neve RM, Lenburg ME and Thompson EW: Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44 (hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia. 15:235–252. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Sheen YY, Kim MJ, Park SA, Park SY and Nam JS: Targeting the transforming growth factor-β signaling in cancer therapy. Biomol Ther (Seoul). 21:323–331. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Savagner P: Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Hay ED: An overview of epithelio-mesenchymal transformation. Acta Anat (Basel). 154:8–20. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Savagner P, Boyer B, Valles AM, Jouanneau J and Thiery JP: Modulations of the epithelial phenotype during embryogenesis and cancer progression. Cancer Treat Res. 71:229–249. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Maeyama M, Koga H, Selvendiran K, Yanagimoto C, Hanada S, Taniguchi E, Kawaguchi T, Harada M, Ueno T and Sata M: Switching in discoid domain receptor expressions in SLUG-induced epithelial-mesenchymal transition. Cancer. 113:2823–2831. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, et al: Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA. 107:15449–15454. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Koh M, Woo Y, Valiathan RR, Jung HY, Park SY, Kim YN, Kim HR, Fridman R and Moon A: Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition. Int J Cancer. 136:E508–E520. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yeh YC, Wu CC, Wang YK and Tang MJ: DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin. Mol Biol Cell. 22:940–953. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hidalgo-Carcedo C, Hooper S, Chaudhry SI, Williamson P, Harrington K, Leitinger B and Sahai E: Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol. 13:49–58. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Eswaramoorthy R, Wang CK, Chen WC, Tang MJ, Ho ML, Hwang CC, Wang HM and Wang CZ: DDR1 regulates the stabilization of cell surface E-cadherin and E-cadherin-mediated cell aggregation. J Cell Physiol. 224:387–397. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Devarajan E, He J, Reddy SP and Dai JL: Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression. Cancer Res. 65:10289–10297. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kamohara H, Yamashiro S, Galligan C and Yoshimura T: Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices. FASEB J. 15:2724–2726. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Jonsson M and Andersson T: Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. J Sci. 114:2043–2053. 2001. | |
|
Hou G, Vogel WF and Bendeck MP: Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. Circ Res. 90:1147–1149. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Neuhaus B, Bühren S, Böck B, Alves F, Vogel WF and Kiefer F: Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors. Cell Mol Life Sci. 68:3757–3770. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Dejmek J, Leandersson K, Manjer J, Bjartell A, Emdin SO, Vogel WF, Landberg G and Andersson T: Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. Clin Cancer Res. 11:520–528. 2005.PubMed/NCBI | |
|
Castro-Sanchez L, Soto-Guzman A, Guaderrama-Diaz M, Cortes-Reynosa P and Salazar EP: Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells. Clin Exp Metastasis. 28:463–477. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Y, Arora P, McCulloch CA and Vogel WF: The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA. J Cell Sci. 122:1637–1646. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Castro-Sanchez L, Soto-Guzman A, Navarro-Tito N, Martinez-Orozco R and Salazar EP: Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells. Eur J Cell Biol. 89:843–852. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hansen C, Greengard P, Nairn AC, Andersson T and Vogel WF: Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. Exp Cell Res. 312:4011–4018. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Dierick H and Bejsovec A: Cellular mechanisms of wingless/Wnt signal transduction. Curr Top Dev Biol. 43:153–190. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Pruitt MM, Letcher EJ, Chou HC, Bastin BR and Schneider SQ: Expression of the wnt gene complement in a spiral-cleaving embryo and trochophore larva. Int J Dev Biol. 58:563–573. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Dale TC: Signal transduction by the Wnt family of ligands. Biochem J. 329:209–223. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Brennan KR and Brown AM: Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia. 9:119–131. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Katoh M: WNT/PCP signaling pathway and human cancer (Review). Oncol Rep. 14:1583–1588. 2005.PubMed/NCBI | |
|
Yang Y: Wnt signaling in development and disease. Cell Biosci. 2:142012. View Article : Google Scholar : PubMed/NCBI | |
|
Roarty K and Serra R: Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth. Development. 134:3929–3939. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshida D and Teramoto A: Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1. J Neurooncol. 82:29–40. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ram R, Lorente G, Nikolich K, Urfer R, Foehr E and Nagavarapu U: Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. J Neurooncol. 76:239–248. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yamanaka R, Arao T, Yajima N, Tsuchiya N, Homma J, Tanaka R, Sano M, Oide A, Sekijima M and Nishio K: Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene. 25:5994–6002. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Assent D, Bourgot I, Hennuy B, Geurts P, Noël A, Foidart JM and Maquoi E: A Membrane-Type-1 Matrix Metalloproteinase (MT1-MMP)-discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells. PLoS One. 10:e01160062015. View Article : Google Scholar : PubMed/NCBI | |
|
Roberts ME, Magowan L, Hall IP and Johnson SR: Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production. Eur Respir J. 37:1482–1493. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Dang N, Hu J, Liu X, Li X, Ji S, Zhang W, Su J, Lu F, Yang A, Han H, et al: CD167 acts as a novel costimulatory receptor in T-cell activation. J Immunother. 32:773–784. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Vogel WF, Aszódi A, Alves F and Pawson T: Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol. 21:2906–2917. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Curat CA and Vogel WF: Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. J Am Soc Nephrol. 13:2648–2656. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Franco C, Ahmad PJ, Hou G, Wong E and Bendeck MP: Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Circ Res. 106:1775–1783. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ambrogio C, Gomez-Lopez G, Falcone M, Vidal A, Nadal E, Crosetto N, Blasco RB, Fernández-Marcos PJ, Sánchez-Céspedes M, Ren X, et al: Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma. Nat Med. 22:270–277. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Duncan JS, Whittle MC, Nakamura K, Abell AN, Midland AA, Zawistowski JS, Johnson NL, Granger DA, Jordan NV, Darr DB, et al: Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell. 149:307–321. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ongusaha PP, Kim JI, Fang L, Wong TW, Yancopoulos GD, Aaronson SA and Lee SW: p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J. 22:1289–1301. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Fanale M: Activated DDR1 increases RS cell survival. Blood. 122:4152–4154. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Das S: Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-B pathway activation. Cancer Res. 66:8123–8130. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Rix U, Hantschel O, Duernberger G, Rix Remsing LL, Planyavsky M, Fernbach NV, Kaupe I, Bennett KL, Valent P, Colinge J, et al: Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib, reveal novel kinase and nonkinase targets. Blood. 110:4055–4063. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Bantscheff M, Eberhard D, Abraham Y, Bastuck S, Boesche M, Hobson S, Mathieson T, Perrin J, Raida M, Rau C, et al: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat Biotechnol. 25:1035–1044. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Barker KT, Martindale JE, Mitchell PJ, Kamalati T, Page MJ, Phippard DJ, Dale TC, Gusterson BA and Crompton MR: Expression patterns of the novel receptor-like tyrosine kinase, Ddr, in human breast-tumors. Oncogene. 10:569–575. 1995.PubMed/NCBI | |
|
Cancer Genome Atlas Network: Comprehensive molecular portraits of human breast tumours. Nature. 490:61–70. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Turashvilia G, Bouchala J, Ehrmanna J, Kolara Z, Fridmanb E and Skardaa J: Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 151:59–64. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Maquoi E, Assent D, Detilleux J, Pequeux C, Foidart JM and Noël A: MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis. Oncogene. 31:480–493. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Juin A, Di Martino J, Leitinger B, Henriet E, Gary AS, Paysan L, Bomo J, Baffet G, Gauthier-Rouvière C, Rosenbaum J, et al: Discoidin domain receptor 1 controls linear invadosome formation via a Cdc42-Tuba pathway. J Cell Biol. 207:517–533. 2014. View Article : Google Scholar : PubMed/NCBI |
